Legal and Financial Powerhouses Behind the Deal
While the financial terms remain undisclosed, industry sources confirmed the acquisition hovers around the €2.6 billion mark. The transaction is subject to regulatory approvals and is expected to close in the coming months.
White & Case LLP is spearheading legal representation for EQT, with a star-studded team led by partner Patrik Erblad, and includes notable names like Michael Weir, Michael Engel, Philip Trillmich, Johan Thiman, and others.
EQT also received financial counsel from Morgan Stanley, Jefferies, and PwC, while Citigroup stepped in as financial adviser to KKR.
The Big Picture: Betting Big on Consumer Health
Karo’s transformation story mirrors a broader trend in private equity—betting on consumer-facing health brands that are nimble, digitally capable, and globally scalable. With consumer health needs shifting toward personalization, prevention, and accessibility, KKR is wagering that Karo can ride that wave straight to the top.
As digital engagement replaces doorstep delivery in the healthcare world, this deal may be KKR’s version of a moonshot.
With the ink barely dry and regulatory hurdles looming, KKR’s acquisition of Karo Healthcare signals the dawn of a new chapter—not just for the companies involved, but for the future of consumer health in Europe and beyond.
